Funded Research
Children’s Brain Tumor Network (CBTN) Precision Medicine
project comprises two interrelated efforts supporting the advancement of recurrent medulloblastoma precision medicine.
2022
2022
Presentation & Publication, Clinical Trial
- Final data Presentation 20th International Symposium on Pediatric Neuro-Oncology
- St. Jude incorporating liquid biopsy technique in the upcoming clinical study for medulloblastoma.
-
Published Cancer Cell Journal.
2022
2022
Funded Research
A Targeted Approach to Medulloblastoma Treatment
2021
Funded Research
Cell-free DNA identifies early signs of relapse in pediatric medulloblastoma
2021
2019
Funded Research
ASCO Young Investigators Award: Cerebrospinal fluid derived circulating tumor DNA as an actionable biomarker in
medulloblastoma, Dr Anthony Lui
2022 Impact Report
look at the impact we can make together
